InvestorsHub Logo

junkHustler

11/13/18 10:34 AM

#78666 RE: drugmanrx #78665

From the 10Q:

s) On September 28, 2018, the Company issued 5,010,000 shares of common stock with a fair value of $3,256,500 to employees of the Company in exchange for services for the Company. The shares vest over periods between 18 and 36 months. During the period ended September 30, 2018, the Company recorded $19,516 for the vested portion of the shares, leaving $3,236,984 of unvested compensation expense to be recognized in future periods.

***

Anything else I can clear up for you?

GLTA & JMO

Ecomike

11/13/18 4:55 PM

#78680 RE: drugmanrx #78665

From the other filing today,

"The maximum number of shares subject to those options and stock appreciation rights that are granted during any calendar year to any individual under the plan is 5,000,000 shares (subject to adjustment post-stock split).


? “Performance-Based Awards” under Section 5.2 of the 2018 Plan granted to a participant in any one calendar year will not provide for payment of more than (1) in the case of awards payable only in cash and not related to shares, $1,000,000, and (2) in the case of awards related to shares (and in addition to options and stock appreciation rights which are subject to the limit referred to above), 5,000,000 shares (subject to adjustment post-stock split). "

Ecomike

11/13/18 5:00 PM

#78681 RE: drugmanrx #78665

100,000,000/200 = 500,000 shares not 5 million shares.

"The maximum number of shares of the Company’s common stock that may be initially issued or transferred pursuant to awards under the 2018 Plan is 100,000,000 shares (which number will be reduced if the reverse stock split takes effect (“post-stock split”)).

In addition, on the first trading day of January each calendar year during the term of the plan (commencing with January 2019)

Ecomike

11/13/18 8:45 PM

#78684 RE: drugmanrx #78665

Page 37 of the 10-Q SGSI

"Salaries and wages were $2,502,408 for the nine months ended September 30, 2018 compared to $4,484,379 for the nine months ended September 30, 2017. This was due to a decrease in stock-based compensation of $2,528,385."